239 related articles for article (PubMed ID: 29587260)
1. Verbascoside Alleviates Atopic Dermatitis-Like Symptoms in Mice via Its Potent Anti-Inflammatory Effect.
Li Y; Yu H; Jin Y; Li M; Qu C
Int Arch Allergy Immunol; 2018; 175(4):220-230. PubMed ID: 29587260
[TBL] [Abstract][Full Text] [Related]
2. Ferulic acid alleviates atopic dermatitis-like symptoms in mice via its potent anti-inflammatory effect.
Zhou Z; Shi T; Hou J; Li M
Immunopharmacol Immunotoxicol; 2020 Apr; 42(2):156-164. PubMed ID: 32122212
[No Abstract] [Full Text] [Related]
3. Effect of isoliquiritigenin for the treatment of atopic dermatitis-like skin lesions in mice.
Yu H; Li H; Li Y; Li M; Chen G
Arch Dermatol Res; 2017 Dec; 309(10):805-813. PubMed ID: 29026975
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effect of 5,6-dihydroergosteol-glucoside on atopic dermatitis-like skin lesions via suppression of NF-κB and STAT activation.
Jung M; Lee TH; Oh HJ; Kim H; Son Y; Lee EH; Kim J
J Dermatol Sci; 2015 Sep; 79(3):252-61. PubMed ID: 26100037
[TBL] [Abstract][Full Text] [Related]
5. Sclareol attenuates the development of atopic dermatitis induced by 2,4-dinitrochlorobenzene in mice.
Wu PC; Chuo WH; Lin SC; Lehman CW; Lien CZ; Wu CS; Lin CC
Immunopharmacol Immunotoxicol; 2019 Feb; 41(1):109-116. PubMed ID: 30704333
[No Abstract] [Full Text] [Related]
6. Sulfuretin alleviates atopic dermatitis-like symptoms in mice via suppressing Th2 cell activity.
Jiang P; Sun H
Immunol Res; 2018 Oct; 66(5):611-619. PubMed ID: 30159861
[TBL] [Abstract][Full Text] [Related]
7. (R)-(+)-pulegone suppresses allergic and inflammation responses on 2,4-dinitrochlorobenzene-induced atopic dermatitis in mice model.
Choi YY; Kim MH; Lee H; Jo SY; Yang WM
J Dermatol Sci; 2018 Sep; 91(3):292-300. PubMed ID: 29933898
[TBL] [Abstract][Full Text] [Related]
8. Improvement of atopic dermatitis with topical application of Spirodela polyrhiza.
Lee HJ; Kim MH; Choi YY; Kim EH; Hong J; Kim K; Yang WM
J Ethnopharmacol; 2016 Mar; 180():12-7. PubMed ID: 26778605
[TBL] [Abstract][Full Text] [Related]
9. The prevention of 2,4-dinitrochlorobenzene-induced inflammation in atopic dermatitis-like skin lesions in BALB/c mice by Jawoongo.
Ku JM; Hong SH; Kim SR; Choi HS; Kim HI; Kim DU; Oh SM; Seo HS; Kim TY; Shin YC; Cheon C; Ko SG
BMC Complement Altern Med; 2018 Jul; 18(1):215. PubMed ID: 30005655
[TBL] [Abstract][Full Text] [Related]
10. Jageum-Jung improves 2,4-dinitrochlorobenzene-induced atopic dermatitis-like skin lesions in mice and suppresses pro-inflammatory chemokine production by inhibiting TNF-α/IFN-γ-induced STAT-1 and NFκB signaling in HaCaT cells.
Yang JH; Do HJ; Lee E; Yim NH; Cho WK; Park KI; Ma JY
J Ethnopharmacol; 2018 Jul; 221():48-55. PubMed ID: 29660465
[TBL] [Abstract][Full Text] [Related]
11. Protective effect of diet supplemented with rice prolamin extract against DNCB-induced atopic dermatitis in BALB/c mice.
Yoon HJ; Jang MS; Kim HW; Song DU; Nam KI; Bae CS; Kim SJ; Lee SR; Ku CS; Jang DI; Ahn BW
BMC Complement Altern Med; 2015 Oct; 15():353. PubMed ID: 26467986
[TBL] [Abstract][Full Text] [Related]
12. The suppressive effect of puerarin on atopic dermatitis-like skin lesions through regulation of inflammatory mediators in vitro and in vivo.
Lee JH; Jeon YD; Lee YM; Kim DK
Biochem Biophys Res Commun; 2018 Apr; 498(4):707-714. PubMed ID: 29524423
[TBL] [Abstract][Full Text] [Related]
13. Artesunate attenuates 2, 4-dinitrochlorobenzene-induced atopic dermatitis by down-regulating Th17 cell responses in BALB/c mice.
Bai XY; Liu P; Chai YW; Wang Y; Ren SH; Li YY; Zhou H
Eur J Pharmacol; 2020 May; 874():173020. PubMed ID: 32087254
[TBL] [Abstract][Full Text] [Related]
14. Anti-inflammatory and immune response regulation of Si-Ni-San in 2,4-dinitrochlorobenzene-induced atopic dermatitis-like skin dysfunction.
Fan HJ; Xie ZP; Lu ZW; Tan ZB; Bi YM; Xie LP; Wu YT; Zhang WT; Liu-Kot K; Liu B; Zhou YC
J Ethnopharmacol; 2018 Aug; 222():1-10. PubMed ID: 29698775
[TBL] [Abstract][Full Text] [Related]
15. Effects of mineral complex material treatment on 2,4- dinitrochlorobenzene-induced atopic dermatitis like-skin lesions in mice model.
Bajgai J; Xingyu J; Fadriquela A; Begum R; Kim DH; Kim CS; Kim SK; Lee KJ
BMC Complement Med Ther; 2021 Mar; 21(1):82. PubMed ID: 33658026
[TBL] [Abstract][Full Text] [Related]
16. Arjunolic acid protects against DNCB-induced atopic dermatitis-like symptoms in mice by restoring a normal cytokine balance.
Alyoussef A
Eur Cytokine Netw; 2015; 26(2):38-45. PubMed ID: 26553587
[TBL] [Abstract][Full Text] [Related]
17. DA-9601 suppresses 2, 4-dinitrochlorobenzene and dust mite extract-induced atopic dermatitis-like skin lesions.
Choi EJ; Lee S; Hwang JS; Im SH; Jun CD; Lee HS; Kim SH
Int Immunopharmacol; 2011 Sep; 11(9):1260-4. PubMed ID: 21511060
[TBL] [Abstract][Full Text] [Related]
18. Topical application of Taglisodog-eum inhibits the development of experimental atopic dermatitis.
Hwang JS; Kim JE; Kim HT; Yu YB; Im SH
J Ethnopharmacol; 2013 Jan; 145(2):536-46. PubMed ID: 23211659
[TBL] [Abstract][Full Text] [Related]
19. Umbelliferone reduces the expression of inflammatory chemokines in HaCaT cells and DNCB/DFE-induced atopic dermatitis symptoms in mice.
Lim JY; Lee JH; Lee DH; Lee JH; Kim DK
Int Immunopharmacol; 2019 Oct; 75():105830. PubMed ID: 31437788
[TBL] [Abstract][Full Text] [Related]
20. Anti-inflammatory effect and metabolic mechanism of BS012, a mixture of Asarum sieboldii, Platycodon grandiflorum, and Cinnamomum cassia extracts, on atopic dermatitis in vivo and in vitro.
Lee G; Park J; Lee H; Kim KS; Park JH; Kyung SY; Kim HS; Yang HO; Jung BH
Phytomedicine; 2023 Jul; 115():154818. PubMed ID: 37187105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
